Medius Holdings Co., Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Medius Holdings Co., Ltd.'s yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
Where ¥100 of sales goes
Latest year (Jun 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
2.0×Over the last 3 years its own operating cash covered its investment spending (capex) 2.0 times.
Higher than 61% of Healthcare companies in Japan.
Cash Locked Ratio
¥3For every ¥100 of sales, ¥3 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥4 tied up three years earlier.
Less money tied up than 74% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Less steady than 55% of Healthcare companies in Japan.
Growth Efficiency Ratio
−¥1Sales grew 26% in 3 years, but profit fell: ¥1 less profit per ¥100 of extra sales.
Lower than 70% of Healthcare companies in Japan.
Asset Productivity Ratio
+26% / +16%In 3 years sales changed by +26% while total assets changed by +16%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
0.0×Debt due within a year is covered 0.0 times by its yearly operating cash.
Lower than 77% of Healthcare companies in Japan.
Cash Cushion Ratio
−50%Debt, after subtracting cash, equals 50% of its market value (net debt).
Lower than 84% of Healthcare companies in Japan.
Tangible Assets Ratio
99%Of every ¥100 the company owns, ¥99 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 65% of Healthcare companies in Japan.
Tangible Net Worth Ratio
92%Of every ¥100 of net worth, ¥92 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 55% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Medius Holdings Co., Ltd. owes ¥0.82 for every ¥1 it owns. Net profit fell 31% in the year to Jun 2026, and shrank 14% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Jun 2026.
P/E ratio
17.7Investors pay ¥17.7 for every ¥1 of Medius Holdings Co., Ltd.'s yearly profit, higher than 58% of Healthcare companies in Japan.
P/B ratio
0.79The share price is 0.79 times Medius Holdings Co., Ltd.'s book value per share, lower than 88% of Healthcare companies in Japan.
Market cap
¥16.4 BThe total market value of all of Medius Holdings Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 51% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥20.7 BWhat Medius Holdings Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥932.55Net worth divided by the number of shares. The share price of ¥737.00 is 0.8 times this, which is the P/B above.
Return on equity (ROE)
4.6%Medius Holdings Co., Ltd. earned 4.6% on its shareholders' money over the last year, lower than 64% of Healthcare companies in Japan.
Owes vs Owns
0.82×Medius Holdings Co., Ltd. owes ¥0.82 for every ¥1 it owns (high), higher than 93% of Healthcare companies in Japan.
Dividend yield
2.68%Medius Holdings Co., Ltd. pays 2.68% of its share price as dividends a year, lower than 53% of dividend-paying Healthcare companies in Japan.
Revenue growth
+5%Revenue rose 5% in the year to Jun 2026, and grew 8% a year on average over 3 years.
Profit growth
-31%Net profit fell 31% in the year to Jun 2026, and shrank 14% a year on average over 3 years.
Profit margin
0.3%Medius Holdings Co., Ltd. keeps ¥0 of every ¥100 of revenue as net profit.
Cash quality
0.4×Cash from Medius Holdings Co., Ltd.'s business was 0.4× its reported profit in the year to Jun 2026 — less cash came in than the profit reported.
Interest cover
10.5×Medius Holdings Co., Ltd.'s operating profit covered its interest costs 10.5 times in the year to Jun 2026.
Cash vs debt
Net debtMedius Holdings Co., Ltd. had ¥8.3 B more debt than cash (net debt) at Jun 2026.
Questions
What is Medius Holdings Co., Ltd.'s P/E ratio?
Investors pay ¥17.7 for every ¥1 of Medius Holdings Co., Ltd.'s yearly profit, higher than 58% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Medius Holdings Co., Ltd.: ¥16.4 B ÷ ¥20.7 B (30 Jun 2026) = 0.8.
What is Medius Holdings Co., Ltd.'s return on equity?
Medius Holdings Co., Ltd. earned 4.6% on its shareholders' money over the last year, lower than 64% of Healthcare companies in Japan.
How much does Medius Holdings Co., Ltd. owe compared with what it owns?
Medius Holdings Co., Ltd. owes ¥0.82 for every ¥1 it owns (high), higher than 93% of Healthcare companies in Japan.
Does Medius Holdings Co., Ltd. pay a dividend?
Yes. Medius Holdings Co., Ltd. pays 2.68% of its share price as dividends a year, lower than 53% of dividend-paying Healthcare companies in Japan.
Is Medius Holdings Co., Ltd.'s revenue growing?
Revenue rose 5% in the year to Jun 2026, and grew 8% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.